4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001104659-20-081211
Options or other derivatives
- Chief Financial Officer acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dahms Bradford D. · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-07-01 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +40,000 | $2.84 | 2030-06-30 | 40,000 | 40,000 | D |
Loading xslF345X03/a4.xml…